Related Experiment Video
Updated: Jul 10, 2026

10:50
Primary Culture of Human Vestibular Schwannomas
Published on: July 20, 2014
13.0K
Stratifying Risk of Future Growth Among Sporadic Vestibular Schwannomas
John P Marinelli1, Zane Schnurman2, Daniel E Killeen3
1Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota.
Summary
Clinicians can stratify growing vestibular schwannomas by initial growth rate to predict future growth. Tumors doubling in volume before initial growth detection often require treatment within 5 years.
Area of Science:
- Neurosurgery
- Oncology
- Radiology
Background:
- Vestibular schwannomas (VS) are tumors that can grow over time.
- Continued observation (wait-and-scan) is an option for some patients with growing VS.
- Predicting subsequent growth is crucial for management decisions.
Purpose of the Study:
- To determine if initial growth behavior can stratify patients with growing sporadic vestibular schwannomas.
- To assess the likelihood of subsequent growth based on initial volumetric growth rate.
Main Methods:
- Analysis of 3,505 serial MRI studies from 952 patients with sporadic VS.
- Volumetric tumor measurements to calculate growth rates.
- Stratification based on annual volumetric growth rate: <25%, 25-50%, 50-100%, and ≥100%.
Main Results:
- Initial growth rate significantly predicted subsequent growth or need for treatment.
- Patients with ≥100% annual growth rate had a 2.01 hazard ratio for subsequent growth/treatment.
- At 5 years, growth-free survival was 31% for <25% growth vs. 6% for ≥100% growth.
Conclusions:
- Initial volumetric growth rate is a reliable stratification tool for growing sporadic VS.
- Tumor growth rate, not age or initial volume, predicts aggressive behavior.
- Nearly all tumors that double in volume before initial growth detection will grow further or require treatment.
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

